4//SEC Filing
WAN MARK A 4
Accession 0001209191-22-042305
CIK 0001427925other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 7:26 PM ET
Size
7.4 KB
Accession
0001209191-22-042305
Insider Transaction Report
Form 4
WAN MARK A
Director
Transactions
- Award
Common Stock
2022-07-15+15,500→ 36,750 total - Award
Stock Option (Right to Buy)
2022-07-15+31,000→ 31,000 totalExercise: $0.23From: 2022-07-15Exp: 2032-07-14→ Common Stock (31,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
- [F3]100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001190472
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 7:26 PM ET
- Size
- 7.4 KB